Skip to main content
Opthea Ltd logo

Opthea Ltd — Investor Relations & Filings

Ticker · OPT ISIN · US68386J2087 LEI · 549300Q5FMFDLP46SF83 ASX Manufacturing
Filings indexed 1,390 across all filing types
Latest filing 2018-11-11 Capital/Financing Update
Country AU Australia
Listing ASX OPT

About Opthea Ltd

https://opthea.com/

Opthea is a clinical-stage biopharmaceutical company focused on developing novel therapies for vision-threatening retinal diseases, particularly wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company's lead product candidate, sozinibercept, is a first-in-class biologic 'trap' inhibitor targeting Vascular Endothelial Growth Factors C and D (VEGF-C and VEGF-D). Sozinibercept is being developed for administration in combination with standard-of-care anti-VEGF-A therapies. This dual-pathway inhibition aims to deliver superior visual outcomes by more comprehensively blocking the mechanisms that contribute to disease progression, addressing the limitations of current treatments that only target VEGF-A. The therapy is being evaluated in late-stage pivotal clinical trials for wet AMD.

Recent filings

Filing Released Lang Actions
Appendix 3B 12 pages 174.2KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to securities issuance. The content includes detailed information about the class and number of securities issued, issue price, purpose, shareholder approvals, and quotation agreements. It does not contain financial statements, management discussion, or audit information. It is a regulatory announcement about capital raising and securities issuance rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed issuance data, confirming it is not a brief announcement or a report publication notice.
2018-11-11 English
Change in substantial holding 3 pages 193.4KB
Regulatory Filings
2018-11-08 English
Appendix 3B 12 pages 174.2KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. The content includes detailed information about the class and number of securities issued, issue price, shareholder approvals, and placement capacity calculations under ASX rules. It does not contain financial statements, earnings data, management discussion, or other report content. Instead, it is a regulatory announcement about capital raising and share issuance activities. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed issuance information, confirming it is not a mere announcement of a report but a substantive filing about capital changes.
2018-11-08 English
Appendix 3B 12 pages 174.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to the issuance of new securities, specifically the issue of fully paid ordinary shares pursuant to the exercise of quoted options. It includes detailed information about the number of securities issued, their terms, issue price, and compliance with ASX rules. The document also contains calculations related to placement capacity under ASX rules 7.1 and 7.1A. This type of document is a formal announcement to the stock exchange about new share issues and capital changes, not a full financial report or earnings release. It fits the category of a Share Issue/Capital Change announcement rather than a full Annual Report, Interim Report, or other financial filings. Therefore, the correct classification is 'SHA' (Share Issue/Capital Change). The document length and content confirm it is not a brief notice or a report publication announcement, but a substantive capital change filing.
2018-11-01 English
Opthea Receives A$12m R&D Tax Incentive 3 pages 70.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX and media release dated 31 October 2018 from Opthea Limited announcing receipt of a A$12 million R&D tax incentive credit for the 2017/2018 financial year. The content focuses on the tax credit, company background, clinical trials, and risks related to biotechnology investment. There are no financial statements, earnings data, or detailed financial analysis present. The document is a corporate announcement about a financing-related event (receipt of a tax credit) rather than a full financial report or earnings release. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The document is best classified as a Capital/Financing Update (CAP) because it provides an update on a significant financing event (R&D tax incentive receipt) impacting the company's cash position and funding for clinical trials.
2018-10-30 English
Letter to Option Holders 4 pages 393.3KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed notice to option holders regarding the exercise of listed options in Opthea Limited. It provides instructions on how to exercise options, payment methods, deadlines, and consequences of not exercising. The content focuses on the option expiry and exercise process rather than financial results, management changes, or regulatory filings. It is not a financial report, earnings release, or regulatory announcement but a shareholder communication about capital changes related to option exercise. This fits the definition of a Share Issue/Capital Change (SHA) filing, as it concerns the exercise of options and issuance of shares upon exercise.
2018-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.